Copyright
©The Author(s) 2022.
World J Gastroenterol. Mar 7, 2022; 28(9): 948-960
Published online Mar 7, 2022. doi: 10.3748/wjg.v28.i9.948
Published online Mar 7, 2022. doi: 10.3748/wjg.v28.i9.948
Table 4 Comparisons of survival outcomes between patients with and without postoperative morbidity
| Survival outcomes | Total (n = 239) | Without postoperative morbidity (n = 93) | With postoperative morbidity (n = 146) | P value |
| Period of follow-up, months1 | 19.0 (11.0, 34.0) | 15.0 (23.0, 41.0) | 16.0 (9.8, 30.0) | 0.001 |
| Death during the follow-up | 160 (66.9) | 55 (59.1) | 105 (71.9) | 0.041 |
| Recurrence during the follow-up | 172 (72.0) | 60 (64.5) | 112 (76.7) | 0.041 |
| OS, months2 | 23.0 (20.0-26.0) | 31.0 (22.4-39.6) | 18.0 (13.0-23.0) | 0.003 |
| 1-yr OS rate, % | 73.4 | 83.8 | 66.7 | |
| 3-yr OS rate, % | 34.0 | 45.5 | 26.7 | |
| 5-yr OS rate, % | 22.9 | 31.7 | 17.0 | |
| RFS, month2 | 19.0 (16.1-21.9) | 26.0 (14.1-37.9) | 16.0 (12.2-19.8) | 0.002 |
| 1-yr RFS rate, % | 64.6 | 75.1 | 54.3 | |
| 3-yr RFS rate, % | 28.7 | 40.8 | 22.4 | |
| 5-yr RFS rate, % | 18.2 | 30.4 | 13.3 |
- Citation: Liu ZP, Chen WY, Zhang YQ, Jiang Y, Bai J, Pan Y, Zhong SY, Zhong YP, Chen ZY, Dai HS. Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma. World J Gastroenterol 2022; 28(9): 948-960
- URL: https://www.wjgnet.com/1007-9327/full/v28/i9/948.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i9.948